HVP – MaxCyte Appoints Chayon Laboratories as Distributor in Korea for the MaxCyte STX® and MaxCyte VLX®
Gaithersburg, MD, September 15, 2015 – MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, announces the appointment of Chayon Laboratories as the exclusive authorized distributor of the MaxCyte STX® Scalable Transfection System and the MaxCyte VLX® Large Scale Transfection System in Korea.
“There has been significant interest and demand for the MaxCyte platform in Korea for drug discovery and protein expression applications. ” stated Karen Donato, Ph.D., Executive Vice President, Business Development & Marketing at MaxCyte. “MaxCyte is pleased to announce the appointment of Chayon Laboratories to expand the reach of our transfection technology in this important and growing market. With an extensive track record of sales and support, Chayon Laboratories will provide a vital link between MaxCyte and this market.”
To view the full article, please click here.